Immuneering Corporation (IMRX) — 分析师展望 / 分析师共识目标价为. 基于 11 位分析师评级, 共识为 看涨 — 7 买入, 4 持有.
分析师共识目标价为 $12.00, 上涨空间为 121.8% 相对于当前价格 $5.41.
分析师预估 每股收益(EPS)为 $-1.79 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-2.04 vs 预期 $-1.79 (不及预期 -13.7%). 2025: 实际 $-1.27 vs 预期 $-1.42 (超预期 +10.4%). 分析师准确度: 88%.
IMRX 股票 — 12个月价格预测
$12.00
▲ +121.81% 上涨空间
平均目标价
Based on 11 Wall Street analysts offering 12-month price targets for Immuneering Corporation, the price target is $12.00.
平均目标价相对最新价格 $5.41 变动 +121.81%。
IMRX 分析师评级
Buy
基于过去3个月内 11 位分析师对 Immuneering Corporation 的评级
EPS 预测 — IMRX
88%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$2.04
vs Est –$1.79
▼ 12.1% off
2025
Actual –$1.27
vs Est –$1.42
▲ 11.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — IMRX
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
